Novo Nordisk (NVO) news
Recent news
Trading resumed: NVOH (Pacific)
Trading resumed for NVOH, the ETF tracking Novo Nordisk A/S (B Shares) ADRhedged, following a period of market inactivity. The fund, which primarily invests in American Depositary Receipts of Novo Nordisk A/S (B Shares), aims to provide exposure to the Danish pharmaceutical giant without direct…
AInvest Wire · 9h agoEuropean software, IT stocks rise, as chip stocks tumble: Nemetzschek, Capgemini, SAP, Temenos, Wolters Kluwer, Relx up 1-3%
European software and IT stocks rose on Monday, with companies such as SAP, Capgemini, and Temenos posting gains of 1-3%. The performance contrasted with a decline in chip stocks, as investors shifted focus toward software and enterprise technology firms. SAP, which recently overtook Novo Nordisk…
AInvest Wire · 15h agoGSK workforce reduction risks about 1200 Belgian jobs: L'Echo
GlaxoSmithKline (GSK) has confirmed a significant reduction in its workforce, with reports indicating that 1,200 jobs in Belgium are at risk, according to L'Echo. This follows a broader restructuring strategy by the pharmaceutical company, which has already announced job cuts in other regions,…
AInvest Wire · 1d agoNvidia also investing in Entalpic
Nvidia has expanded its investment portfolio by allocating significant capital to Entalpic, a startup specializing in AI-driven materials and chemistry research. The investment aligns with Nvidia’s broader strategy to integrate AI and accelerated computing into scientific and engineering workflows,…
AInvest Wire · 2d agoWalmart's list of covered medications include GLP1s like Novo's Ozempic and Lilly's Mounjaro, alongside some insulin and inhalers - Bloomberg News
Walmart has expanded its pharmacy coverage to include glucagon-like peptide-1 (GLP-1) weight-loss medications such as Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro, according to Bloomberg News. These additions come amid growing demand for prescription weight-management therapies and reflect a…
AInvest Wire · 2d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.